Brian T. Chan-Kai, M.D.
Retina Specialist
Board Certified, American Board of Ophthalmology
Click here to read about Dr. Chan-Kai's Education
Dr. Chan-Kai is a board certified ophthalmologist, specializing in Vitreoretinal disease and surgery.
Dr. Chan-Kai graduated from the University of California in 1998 with a B.S. in Microbiology and Molecular Genetics. He subsequently attended medical school at the Medical College of Wisconsin where he was elected to the Alpha Omega Alpha medical student honor society.
After earning his medical degree, Dr. Chan-Kai completed both his Internship in 2004 and his Residency in Ophthalmology in 2007 at Baylor College of Medicine Affiliated Hospitals. After deciding to sub-specialize in Vitreoretinal Diseases and Surgery and Ocular Oncology, he was accepted as a fellow at OHSU’s Casey Eye Institute for a 2 year Vitreoretinal fellowship program from 2007 – 2009.
Dr. Chan-Kai has participated in many research programs as well as having several published papers in medical journals. He has also been invited to present his research at both national and local meetings and seminars. Dr. Chan-Kai is an active member of the American Academy of Ophthalmology, The American Medical Association, The Association for Research in Vision and Ophthalmology, The American Society of Retinal Specialists and the Oregon Academy of Ophthalmology.
While Dr. Chan-Kai has enjoyed practicing and teaching at Baylor College of Medicine for the past 2 years, he and his family wanted to return to the Portland area. Dr. Chan-Kai will join the staff of EyeHealth Northwest in August of 2011.
| GENERAL BIOGRAPHICAL INFORMATION | |
| Name: Brian T. Chan-Kai, M.D. | |
| EDUCATION |
|
| Undergraduate | University of California Los Angeles, CA Bachelor of Science Major: Microbiology and Molecular Genetics 1994 – 1998 |
| Medical School | Medical College of Wisconsin Milwaukee, WI Doctor of Medicine 1999 – 2003 |
| Internship | Baylor College of Medicine Affiliated Hospitals Houston, TX Thomas Vargo, M.D., Director 2003 – 2004 |
| Residency | Baylor College of Medicine Affiliated Hospitals Department of Ophthalmology Houston, TX Elizabeth Baze, M.D., Director 2004 – 2007 |
| Fellowship: | Oregon Health and Science University Casey Eye Institute/ Devers Eye Institute Vitreoretinal Diseases and Surgery Portland, OR Andreas Lauer, M.D., Director 2007 – 2009 |
| ACADEMIC APPOINTMENTS |
|
| Assistant Professor | Vitreoretinal Diseases and Surgery Department of Ophthalmology Baylor College of Medicine Houston, TX September 2009 to Present |
| Instructor | Department of Ophthalmology Oregon Health and Science University Casey Eye Institute/Devers Eye Institute Portland, OR 2007 – Present |
| Chief Resident and Instructor | Department of Ophthalmology Baylor College of Medicine Houston, TX 2006 - 2007 |
| OTHER INFORMATION |
|
| Honors/Awards | Golden Key National Honor Society,1997 University of California Los Angeles, CA Phi Beta Kappa, 1998 University of California Los Angeles, CA Department of Microbiology Section Honors,1998 University of California Los Angeles, CA President’s Undergraduate Fellowship for Research, 1998 University of California Los Angeles, CA Provost’s Honor List, 1998 University of California Los Angeles, CA Outstanding Project and Presentation, 2000 Medical College of Wisconsin Milwaukee, WI Hanus Scholarship, 2002 Medical College of Wisconsin Milwaukee, WI Alpha Omega Alpha, 2002 Medical College of Wisconsin Milwaukee, WI Award for Teaching Excellence, 2006, 2007 Baylor College of Medicine Houston, TX Travel Grant, 2008 Association for Research in Ophthalmology Annenberg Center Mentoring in Ophthalmology, 2008 Research Program |
| BOARD CERTIFICATION: | American Board of Ophthalmology, Diplomate, 2008 |
| LICENSURE: | Oregon: MD27367 Texas: N3546 |
| RESEARCH INFORMATION |
|
| Support | 1.) Age-related Eye Disease Study 2 (AREDS2). Multicenter randomized trial. National Eye Institute Sub-Investigator 2007 - 2009 Contract 2.) A Retrospective Chart Review of Patients with Neovascular Age-Related Macular Degeneration Treated with Intravitreal Anti-VEGF Therapy and Time to Remission. Sub-Investigator 2007 - 2009 3.) Validation of the Molecular Test for Predicting Metastasis in Patients with Uveal Melanoma. Sub-Investigator 2007 - 2009 4.) Evaluation of Efficacy and Safety of Posterior Juxtascleral Administration of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study “A” or Study “B”) at Risk for Developing Sight-Threatening Choroidal Neovascularization (CNV) Due to Exudative Age-Related Macular Degeneration (AMD). Alcon - #C-02-60 Sub-Investigator 2007 - 2009 Contract 5.) The Effect of Genotype and Environmental Risk Factors on Treatment Response to Intravitreal Lucentis (Ranibizumab) for Neovascular AMD, Phase IV Clinical Trial Genentech Sub-Investigator 2007 - 2009 Contract 6.) Phase II Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects with Age-Related Macular Degeneration. Serion Therapeutics Sub-Investigator 2007 - 2009 Contract 7.) Phase II Multicenter, Randomized Study of the Efficacy of Ciliary Neurotrophic Factor (CNTF) Delivered via Encapsulated Cell Technology (ECT) Product for the Treatment of Visual Loss Associated with Retinitis Pigmentosa. National Eye Institute Sub-Investigator 2007 - 2009 Contract |
| National Scientific Participation | Peer Reviewer – Journals Eye, 2009- Present Ophthalmology. 2007 - Present Retina, 2007 – Present Journal of the American Association of Pediatric Ophthalmology and Strabismus, 2009-present |
| PROFESSIONAL SOCIETIES: | American Academy of Ophthalmology American Medical Association American Society of Retina Specialists Association for Research in Vision and Ophthalmology Houston Ophthalmologic Society Oregon Academy of Ophthalmology Texas Ophthalmologic Society |
| INVITED LECTURES, PRESENTATIONS, RESEARCH SEMINARS |
Flaxel CJ, Chan-Kai B. Inferior Exudates in Central Serous Chorioretinopathy. World Ophthalmology Congress, Hong Kong, July 2008 Witherspoon SR, Chan-Kai B, Flaxel C. Shooting Baskets in the Wrong Hoop. The Retina Society, Scottsdale, Arizona, September 2008. Yeh S, Forooghian F, Weichel ED, Wong WT, Faja LJ, Chan-Kai B, Witherspoon SR, Lauer AK, Chew EY, Nussenblatt RB. Fundus Autofluorescence Imaging in the Evaluation of Cytomegalovirus Retinitis. American Society of Retina Specialists, Maui, Hawaii, October 2008 Witherspoon SR, Chan-Kai BT, Weleber R, Watzke R, Lauer AK. Atypical Acute Retinal Pigment Epithelitis (Fluorescein Angiography). American Society of Retina Specialists, Maui, Hawaii, October 2008. Chan-Kai BT, Witherspoon SR, Weleber RG, Lauer AK. Electroretinographic Findings and Autoretinal Antibodies in Transplant Chorioretinopathy. American Society of Retina Specialists, Maui, Hawaii, October 2008. Chan-Kai BT. Management of Cystoid Macular Edema: Macular Edema in Hereditary Retinal Disorders. American Academy of Ophthalmology, Atlanta, Georgia. November 2008. Chan-Kai BT. Ophthalmic Anatomy for the Retinal Technician. Joint Commision on Allied Health Personnel Annual Meeting, Atlanta, Georgia. Novermber 2008. Simmons-Rear A, Yeh S, Chan-Kai BT, Lauer AK, Flaxel CJ, Smith JR, Rosenbaum JT, Suhler E. Characterization of Serous Retinal Detachments in Uveitis Patients with Optical Coherence Tomography. The Association for Research in Vision and Ophthalmology, Fort Lauderdale, Florida, May 2009. Chan-Kai BT. Update on Management and Treatment of Intraocular Lymphoma. Cullen Course, Baylor College of Medicine. Houston, Texas. Feb 2010 Chan-Kai BT. DRCR Trials-How Have They Impacted Macular Edema Treatment. Cullen Course, Baylor College of Medicine. Houston, Texas. Feb 2010 Chan-Kai BT. Leukocoria: Retinal Considerations. Cullen Course, Baylor College of Medicine. Houston, Texas. Feb 2011 Chan-Kai BT. Intermediate Uveitis. Cullen Course, Baylor College of Medicine. Houston, Texas. Feb 2011 Chan-Kai BT. Pigmented Choroidal Lesions: What You Need to Know. Cullen Course, Baylor College of Medicine. Houston, Texas. Feb 2011 |
| PUBLICATIONS | Full Papers Published – Peer Reviewed Journals: Chan-Kai BT, Yen MT. Combined positron emission tomography/computed tomography imaging of orbital lymphoma. Am J Ophthalmol 2005; 140:531-533. Chan-Kai BT, Yen MT. Lower eyelid entropion in Langer-Giedion syndrome. Ophthal Plast Reconstr Surg 2006; 22:59-60. Lakhanpal RR, Fortun JA, Chan-Kai B, Holz ER. Vitrectomy and lensectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity. Retina 2006; 26:736-740. Foroozan R, Chan-Kai B, Marx DP. Dilated conjunctival vessels in a patient undergoing epoprostenol therapy. Clinical & Experimental Ophthalmology 2007; 35:877-878. Yang S, Borirakchanyavat S, Chan-Kai BT, Stout JT, Fu AD. Diagnostic and therapeutic challenges. Retina 2009; 29:708-714. Chan-Kai BT, Lauer AK. Transconjunctival, sutureless 25-gauge lens sparing vitrectomy for stage 4 retinopathy of prematurity-related retinal detachments. Retina 2009; 29:854-859. Yeh S, Forooghian F, Faia LJ, Weichel ED, Wong WT, Sen HN, Chan-Kai BT, Witherspoon SR, Lauer AK, Chew EY, Nussenblatt RB. HYPERLINK"http://www.ncbi.nlm.nih.gov/pubmed/19996825"Fundus autofluorescence changes in cytomegalovirus retinitis. Retina. 2010 Jan;30(1):42-50. ACCORD Study Group. "http://www.ncbi.nlm.nih.gov.ezproxyhost.library.tmc.edu/pubmed/20587587"Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010 Jul 15;363(3):233-44. Epub 2010 Jun 29. Chan-Kai BT, Yeh S, Witherspoon SR, Francis PJ, Weleber RG, Lauer AK. Electoretinographic Findings in Transplant Chorioretinopathy. Clinical Ophthalmology. 2010 Jul 30; 4:777-83 Non Peer-Reviewed Journals Chan-Kai BT. Macular Degeneration. Houston Medical Journal. Feb 2010. Abstracts (last 3 years) Chan-Kai BT, Carvounis PE, Manzano RP, Fortun JA, Kim HH, Albini TA, Kopel AC, Holz ER. Factors influencing visual outcomes following treatment for retinal pigment epithelium detachments associated with age-related macular degeneration. Investigative Ophthalmology & Visual Science 2007; 48:E-Abstract 3390. Carvounis PE, Kim HH, Manzano RP, Fortun JA, Chan-Kai BT, Albini TA, Holz ER. Anatomical outcomes following treatment for retinal pigment epithelium detachment associated with age-related macular degeneration. Investigative Ophthalmology & Visual Science 2007; 48:E-Abstract 1802. Chan-Kai BT, Lauer AK. Sutureless, transconjunctival 25-gauge vitrectomy for stage 4A retinopathy of prematurity related retinal detachments. Investigative Ophthalmology & Visual Science, 2008; 49:E-Abstract Chan-Kai BT, Yeh S, Smith JR, Flaxel CJ, Lauer AK, Rosenbaum JT, Suhler EB. Correlation of visual acuity and optical coherence tomography findings in patients with birdshot chorioretinopathy. Investigative Ophthalmology & Visual Science 2009; 50:E-Abstract |
| TEACHING INFORMATION |
Didactic Course Work Courses Taught at Baylor College of Medicine Ophthalmology Department: Fluorescein Angiography Conference, 10 – 20 hours per year Ophthalmology resident lectures: Vitreoretinal diseases and surgery, 10 – 15 hours per year. Cullen Course, Continuing education topics in vitreoretinal diseases and surgery, 1 – 2 hours per year Non-didactic Teaching at Baylor College of Medicine Resident Training Clinical: Resident instruction in vitreoretinal diseases and surgery, 20-30 hours per week Clinical: Staffing of resident clinic and surgery at Ben Taub General Hospital, 4-6 hours per week Clinical: Staffing of resident clinic and surgery at Michael E. DeBakey Veterans’ Administration Medical Center, 4-6 hours per week Clinical Fellow Training Andrew J. Barkmeier, M.D., Houston, Texas, 2009-2010 Golnaz Javey, M.D., Houston, Texas, 2009-Present Usha Pinninti, M.D., Houston, Texas, 2010-Present Clinical: Mentorship – 20 hours per week Research Fellow Training Andrew J. Barkmeier, M.D., Houston, Texas, 2009-Present Golnaz Javey, M.D., Houston, Texas, 2009-Present Research: Mentorship – 4 to 5 hours per week Medical Student Mentoring |
| LECTURES | National Overcoming Macular Degeneration. Fox Houston Morning News. May 2010. Retinitis Pigmentosa-Current and Future Treatements. Foundation for Fighting Blindness. Houston, Texas. March 2009. Sutureless, transconjunctival 25-gauge vitrectomy for stage 4A retinopathy of prematurity related retinal detachments. Casey Eye Institute. Portland, Oregon, 2008 Local Autoimmune and Paraneoplastic Retinopathy. Baylor College of Medicine, Houston, Texas, September 2009 Intraocular lymphoma. Baylor College of Medicine, Houston, Texas, September 2009 Factors influencing visual outcomes following treatment for retinal pigment epithelium detachments associated with age-related macular degeneration. Baylor Ophthalmology Alumni Association Day, Houston, Texas, June 2007 Variations in central corneal thickness with changes in intraocular pressure, pilot study. Baylor Ophthalmology Alumni Association Day, Houston, Texas, June 2006. Update on the treatment of ocular cicatricial pemphigold. Cornea Conference, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, 2005. |
See Our Laser Vision Correction website
Are you a potential LASIK candidate? LASIK eye surgery can correct nearsightedness, farsightedness and astigmatism. 0% financing programs available.
See Better After Cataract Surgery!
Cataract patients now have an option to see at both near and far distances after cataract surgery! Individuals suffering from cataracts previously had only a mono-focal lens implant option after surgery. NEW premium lens implant technology can now decrease dependence on glasses after surgery.
